UCSF Medical Center
Locations
Transplant Summary
Overview
UCSF is recognized as one of the top hospitals in the nation and is an active center for research and hematopoietic stem cell transplantation. Our adult program utilizes myeloablative and non-myeloablative approaches for patients with leukemia, myelodysplasia, lymphoma, myeloma and selected solid tumors. The adult program uses the following hematopoietic cell sources: matched related, matched unrelated, haploidentical related, and umbilical cord blood. Our pediatric program treats children with hematologic cancers, brain tumors, neuroblastoma, genetic diseases and immunodeficiency disorders, and specializes in haploidentical related donor transplants.This center has been performing allogeneic transplants since 1982 and has been an NMDP transplant center since March 1991.
Attending physicians
Adult - Weiyun Ai, Charalambos Andreadis, Shagun Arora, Alfred Chung, Neil Dunavin, Tim Ferng, Karin Gaensler, Carrie Ho, Lawry Kaplan, Jerry Lee, Jodi Lipoff, Aaron Logan, Thomas G Martin, Mwanasha Merrill, Rebecca Olin, Tamar Othman, Darren Pan, Peter Sayre, Madhav Seshadri, Nina Shah, Catherine Smith, Michael Spinner, Jeffrey Wolf
Pediatric - Serine Avagyan, Julia Chu, Christopher Dvorak, Michelle Hermiston, Christine Higham, James Huang, Sandhya Kharbanda, Philip Paurstein, Gabriel Salinas-Cisneros, Kristin Shimano, William Temple, Lena WinestoneTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult and pediatricOther programs and services
Family House for pediatric patients living 50 miles from the Medical Center. For adults, we currently offer discount housing and Koz Hospitality House for patients and their caregivers after recovering from transplant.Patient survival information for this center
University of California - San Francisco - Adults
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 215 patients.The actual 1-year survival of these patients is 75.3%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 68.2% and 79.5%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.University of California - San Francisco - Pediatrics
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 82 patients.The actual 1-year survival of these patients is 86.6%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 77.9% and 92.5%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
445
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow6PBSC79Cord blood0Total85Unrelated donorMarrow3PBSC81Cord blood0Total84Total allogeneicMarrow9PBSC160Cord blood0Total169AutologousMarrowBoth marrow & PBSC 276PBSC—Cord blood—Total276Total combinedMarrowBoth marrow & PBSC 445PBSC—Cord blood0Total445Total pediatric transplants
100
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow7PBSC34Cord blood3Total44Unrelated donorMarrow6PBSC9Cord blood0Total15Total allogeneicMarrow13PBSC43Cord blood3Total59AutologousMarrowBoth marrow & PBSC 41PBSC—Cord blood—Total41Total combinedMarrowBoth marrow & PBSC 97PBSC—Cord blood3Total100All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-183619-444045-643365+20Total129Unrelated 0-181319-441945-642965+38Total99Autologous 0-183719-444445-6415065+86Total317Total 0-188619-4410345-6421265+144Total545Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
This center has separate survivorship programs for adult and pediatric patients.
Please select the program you are interested in.